DelveInsight Estimates Diverse Bispecific Antibody Pipeline Comprising 180+ Key Companies Working in the Domain
Over 180+ companies are evaluating 250+ drugs in various stages, and their anticipated acceptance in the market would significantly increase the revenue. LAS VEGAS, CALIFORNIA, UNITED STATES OF AMERICA, March 20, 2024 /EINPresswire.com/ -- DelveInsight …